3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
5
Rectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Head and Neck Neoplasms
4
Glioblastoma
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Breast Neoplasms
3
Brain Neoplasms
3
Astrocytoma
3
Recurrence
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Oropharyngeal Neoplasms
2
Mouth Neoplasms
2
Lung Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Wilms Tumor
1
Skin Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Surgical Procedures, Operative
×
90 days
×
Clear all
No trials found.